Citigroup’s Decoy Therapeutics DCOY Stock Holding History

Citigroup’s Portfolio DCOY Stock Details DCOY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-33	Closed	-$5.28K	–	6301
2025 Q2	$5.28K	Buy	+33	New	+$4.64K	﹤0.01%	5274
2024 Q4	–	Sell	-9	Closed	-$2.32K	–	5946
2024 Q3	$2.32K	Buy	+9	New	+$3.22K	﹤0.01%	5404
2017 Q2	–	Hold	0	–	–	–	7463
2017 Q1	–	Hold	0	–	–	–	7323
2016 Q4	–	Hold	0	–	–	–	7315
2016 Q3	–	Hold	0	–	–	–	6676
2016 Q2	–	Hold	0	–	-$74K	–	7400
2016 Q1	–	Hold	0	–	–	–	5874
2015 Q4	–	Hold	0	–	–	–	5929
2015 Q3	–	Hold	0	–	–	–	7682
2015 Q2	–	Hold	0	–	–	–	7330
2015 Q1	–	Hold	0	–	–	–	6081

Other funds holding DCOY

ASN

Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

Citigroup's DCOY Position: Q3 2025 in Review

Citigroup sold out of Decoy Therapeutics (DCOY) in Q3 2025, closing a stake of 33 shares — an estimated $5.28K sold.

Citigroup first reported a position in DCOY in Q3 2024 and held it in 2 quarters. The position peaked at $5.28K in Q2 2025. 3 funds tracked by Wall St. Rank hold DCOY as of Q3 2025.

Citigroup reported no remaining Decoy Therapeutics position as of Q3 2025 after selling out during the quarter.
Citigroup sold 33 Decoy Therapeutics shares in Q3 2025, an estimated $5.28K.
Citigroup first reported a position in Decoy Therapeutics in Q3 2024 and held it in 2 quarters.
Citigroup's Decoy Therapeutics position peaked at $5.28K in Q2 2025.
3 funds tracked by Wall St. Rank held Decoy Therapeutics as of Q3 2025.

Based on Citigroup's 13F filing for Q3 2025, filed 10 Nov 2025.